新闻中心

News Center

The 2019 Foncoo Pharmaceutical Agents Conference ended successfully

Release Time

2022-06-21 16:12

       

  On December 14, 2019, Foncoo Pharmaceutical's 2019 Annual Agents Meeting was held in Shenzhen. A total of 25 agents from Oran were invited to participate in the meeting, and company leaders such as Foncoo Pharmaceutical Chairman Mr. Qin Cheng, Deputy General Manager Mr. Fu Qun, Marketing Director Mr. Qian Fangping, and Chief Financial Officer Ms. Yan Xiaohui attended the meeting.

  Mr. Qin Cheng, chairman of the company, made a keynote speech on "customer first". Marketing Director Mr. Qian Fangping reviewed the sales and market performance of Oran in 2019, expressed his loyalty and gratitude to all Oran agents, looked forward to the future, faced opportunities and adjustments, and worked together with partners through cooperation. Create the future. During the meeting, Ms. Luo Jianying, Partner of KPMG China Tax Service, was invited to give a special speech on "2019 Tax Collection Environment and Audit Response", and three representative provinces were invited to share cases. Finally, the company commends and awards outstanding agents to share the joy of success.

 
 
 
 
 
 

 

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称